3Wistuba II , Albores - Saavedra J. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. J Hepatobil Pancreat Surg, 1999,6(3) : 237 - 244.
4Mikami T, Yanagisawa N, Baba H, et al. Association of Bcl - 2 protein expression with gallbladder carcinoma differentiation and progression and its relation to apoptosis. Cancer, 1999,85(2) : 318- 325.
5Tatsumoto T, Nakano S, Shimizu K, et al. Direct tumorigenic conversion of human gallbladder carcinoma cells by v - src but not by activated c- H- ras oncogene. Int J Cancer, 1995,61(2) : 206-213.
6Lee CS. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours. Eur J Surg Oncol, 1998, 24(1).. 38-42.
7Itoi T, Shinohara Y, Takeda K, et al. Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis. J Gastroenterol,2000,35(2) : 142 - 149.
8Saetta A, Lazaris AC, Davaris PS. Detection of ras oncogene point mutation and simultaneous proliferative fraction estimation in gallbladder cancer. Pathol Res Pract, 1996,192(6) :532 - 540.
9Iwase T, Nakazawa S, Yamao K, et al. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary duets. Hepatogastroenterology, 1997,44 ( 17 ) : 1457- 1462.
10Roa I, Aretxabala X, Araya JC, et al. Incipient gallbladder carcinoma - clinical and pathological study and prognosis in 196 cases.Rev Med Chil, 2001,129(10): 1113- 1120.
